Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/1997
10/23/1997WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997WO1997039120A2 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997WO1997039008A1 Detection probes, kits and assays
10/23/1997WO1997038718A1 Novel compounds
10/23/1997WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997CA2251945A1 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/22/1997EP0802259A1 Cyclodextrin glucosyltransferases for the production of gamma-cyclodextrin
10/22/1997EP0679093B1 Methods of delivering agents to target cells
10/22/1997CN1162743A Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides
10/22/1997CN1162641A Cyclodextrin glycosyl transferases for producing r-cyclodextrin
10/21/1997US5679785 3'(2')-amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation thereof
10/21/1997US5679774 DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
10/21/1997US5679555 Method of using ribozyme analogs having rigid, non-nucleotidic molecular linkers
10/21/1997US5679553 Process for rendering a nucleic acid amplication reaction product incapable of being a target for further amplification, a diagnostic assay employing said process
10/21/1997US5679548 Inducing mutagenesis of a complementarity determining region (cdr) of an immunoglobulin heavy or light chain gene; amplification of the cdr; genetic engineering
10/21/1997US5679517 Analytical methods and probes for the identification of chromosomal aberrations and the diagnosis of genetically-based disease states
10/21/1997US5679512 Method for introducing defined sequences at the 3'end of polynucleotides
10/21/1997US5679510 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
10/21/1997US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/18/1997CA2199904A1 Cyclodextrin glycosyl transferases for producing .gamma.-cyclodextrin
10/16/1997WO1997038137A1 Hereditary hemochromatosis gene
10/16/1997WO1997038135A1 Detecting genetic predisposition for osteoporosis
10/16/1997WO1997038134A1 Method for detecting a target compound using a nucleic acid ligand
10/16/1997WO1997038131A1 Method for detecting a nucleic acid chain to be analysed
10/16/1997WO1997038125A1 Methods for the diagnosis and prognosis of cancer
10/16/1997WO1997038121A1 α2 SUBUNIT OF PROLYL-4-HYDROXYLASE NUCLEIC ACID SEQUENCES ENCODING SUCH SUBUNIT AND METHODS FOR PRODUCING THE SAME
10/16/1997WO1997037999A1 Synthetic triple helix-forming compounds
10/16/1997WO1997037966A1 Quaternary cytofectins
10/16/1997WO1997037691A1 Telomerase inhibitors
10/16/1997WO1997030975A3 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
10/16/1997CA2251757A1 .alpha.2 subunit of prolyl-4-hydroxylase nucleic acid sequences encoding such subunit and methods for producing the same
10/16/1997CA2250525A1 Method for detecting a target compound using a nucleic acid ligand
10/15/1997EP0801072A2 Selective photoinduced flavin-dependent cleavage of rna at g-u base pairs
10/15/1997EP0800588A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
10/15/1997EP0800587A1 Comparative fluorescence hybridization to nucleic acid arrays
10/15/1997EP0800586A1 Oligonucleotide clamps having diagnostic and therapeutic applications
10/15/1997EP0800526A1 Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides
10/15/1997EP0646013A4 Platelet derived growth factor antagonists.
10/15/1997EP0294469B1 Vaccines and diagnostic assays for haemophilus influenzae
10/15/1997CN1162337A Process of producing beta-lactam antibiotics applying microorganisms with increased ligase activity
10/15/1997CN1162317A Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
10/15/1997CN1162316A Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
10/15/1997CN1162266A Novel brain endothelial cell protein and methods for its use
10/14/1997US5677441 Biosynthesis; exocyclic amino groups protected by phenyl acetate groups
10/14/1997US5677440 Oligonucleotide-polyamide conjugates
10/14/1997US5677439 Prevention gene expression
10/14/1997US5677437 Macromolecules; regulating rna expression; therapy
10/14/1997US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase
10/14/1997US5677426 Anti-IL-8 antibody fragments
10/14/1997US5677289 Method of cleaving specific strands of RNA and medical treatments thereby
10/14/1997US5677278 Truncated keratinocyte growth factor (KGF) having increased biological activity
10/14/1997US5677277 Brain disorders
10/14/1997US5677195 Forming oligonucleotides or peptides by forming flow channels in substrate surface, each of flow channels comprising walls which form fluid-tight seals with surface and a flow intake and outlet, flowing nucleic acids through channels to bind
10/14/1997US5677159 Genomic DNA of human cholesterol 7α-hydroxylase and methods for using it
10/14/1997US5677149 Culturing under suitable conditions a host cell transformed or trasnfected with a replicable vector comprising specific nucleic acid sequence in a manner allowing expression of the polypeptide and recovering transformed polypeptide
10/14/1997US5677148 Genetic engineering
10/14/1997US5677130 BCL-1 locus nucleic acid probes and assay methods
10/14/1997US5676965 Use of polydeoxyribonucleotides in diabetic neuropathies
10/14/1997US5676943 Nerve growth factor
10/14/1997US5676941 Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor
10/10/1997CA2190812A1 Polypeptide
10/09/1997WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein
10/09/1997WO1997037018A1 Novel gene
10/09/1997WO1997036960A1 Asymmetric benzoxanthene dyes
10/09/1997WO1997036931A1 An assay system and novel labelled compounds for use therewith
10/09/1997WO1997036916A1 dUTPASE, ITS ISOFORMS, AND DIAGNOSTIC AND OTHER USES
10/09/1997WO1997032018A3 Hepatitis c virus ribozymes
10/08/1997EP0799890A2 Recombinant inactive core streptavidin mutants
10/08/1997EP0799835A2 Anti-fibroblast growth factor-8 monoclonal antibody
10/08/1997EP0799312A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
10/08/1997EP0777679A4 Delivery of nucleic acids
10/08/1997EP0691978B1 Electronically conductive polymer/nucleotide copolymer, preparation method therefor and use thereof
10/08/1997EP0544757B1 Novel polyamine conjugated oligonucleotides
10/08/1997EP0506892B1 Boronated nucleosides
10/07/1997US5674978 Peptides derived from glutamic acid decarboxylase
10/07/1997US5674856 Modified oligodeoxyribonucleoditides
10/07/1997US5674835 Papillomaviral expression inhibitors
10/07/1997US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997US5674743 Cleaving single nucleotide from dna strand; incorporating in fluorescence-enhancing matrix; irradiating; identifying; repeating
10/07/1997US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid
10/07/1997US5674685 Systematic evolution of ligands bu exponential enrichment
10/02/1997WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035869A1 Dinucleotide and oligonucleotide analogues
10/02/1997WO1997035591A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/02/1997CA2250452A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997CA2248318A1 Growth factor htter36
10/01/1997EP0797683A1 Methods and apparatus for dna sequencing and dna identification
10/01/1997EP0797682A2 Purification of a triple helix formation with an immobilized oligonucleotide
10/01/1997EP0797676A2 Recombinant adenoviral vector and methods of use
10/01/1997EP0797580A2 Nucleoside derivatives with photolabile protective groups
10/01/1997EP0694075A4 Thermostable dna topoisomerase v
10/01/1997EP0673440A4 Mammalian muscle nad:arginine adp-ribosyltransferase.
09/1997
09/30/1997US5672697 Form oligonucleotides stable to nuclease degradation
09/30/1997US5672695 Modified ribozymes
09/30/1997US5672511 Base-modified enzymatic nucleic acid
09/30/1997US5672501 Base-modified enzymatic nucleic acid